Effect of chlorpheniramine on the pharmacokinetics of and response to chloroquine of Nigerian children with falciparum malaria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 3, 1999, Pages 306-311

  Okonkwo, C A ^a   Coker, H A B ^b   Agomo, P U ^a   Ogunbanwo, J A ^a   Mafe, A G ^a   Agomo, C O ^a   Afolabi, B M ^a  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Children; Chloroquine; Chlorpheniramine; Drug resistance; Malaria; Nigeria; Pharmacokinetics; Plasmodium falciparum

Indexed keywords

CHLOROQUINE; CHLORPHENIRAMINE;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; GIEMSA STAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA FALCIPARUM; NIGERIA; ORAL DRUG ADMINISTRATION; PARASITEMIA; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032772698     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90033-0     Document Type: Article

References (18)

1. Adelusi, S. A., Dawodu, A. H. & Salako, L. A. (1982). Kinetics of the uptake and elimination of chloroquine in children with malaria. British Journal of Clinical Pharmacology, 14, 483-487.
2. Alvan, G., Ekman, L. & Lindstrom, B. (1982). Determination of chloroquine and its desethyl-metabolite in plasma, red cell and urine by liquid chromatography. Journal of Chromatography, 229, 241-247.
3. Basco, L. K. & Le Bras, J. (1994). In vitro reversal of CQ resistance with chlorpheniramine against African isolates of P. falciparum. Japanese Journal of Medical Science and Biology, 47, 59-63.
4. Bergqvist, Y., Ericsson, O. & Rais, M. (1986). Determination of chloroquine in dried blood spots on filter-paper. Importance of sample handling. Therapeutic Drug Monitoring, 8, 211-213.
5. Bruce-Chwatt, L. J. (1981). Drug resistance in malaria. In: Chemotherapy of Malaria, 2nd edition. Geneva: World Health Organization, pp. 102-118.
6. Gustafsson, L. L., Walker, O., Alvan, G., Beerman, B., Estevez, F., Gleisner, L., Lindstrom, B. & Sjoqvist, F. (1983). Disposition of chloroquine in man after single intravenous and oral doses. British Journal of Clinical Pharmacology, 15, 471-479.
7. Hellgren, U., Kihamia, C. M., Mahikwano, L. F., Bjorkman, A., Eriksson, O. & Rombo, L. (1989). Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and DCQ. Bulletin of the World Health Organization, 67, 197-202.
8. Lindquist, N. G. (1973). Accumulation of drugs on melanin. Acta Radiologica-supplementum (Stockholm), 325, 1-92.
9. Martin, S. K., Oduola, A. M. J. & Milhous, W. K. (1987). Reversal of chloroquine resistance in P. falciparum by verapamil. Science, 235, 899-901.
10. Moore, D. V. & Lanier, J. E. (1961). Observation of two P. falciparum infections with abnormal response to chloroquine. American Joumal of Tropical Medicine and Hygiene, 10, 5.
11. Peters, W., Ekong, R., Robinson, B. L. & Warhurst, D. C. (1989). Antihistaminic drugs that reverse chloroquine resistance in P. falciparum. Lancet, ii, 334-335.
12. Simons, F. E. R., Luciuk, G. H. & Simons, K. J. (1982). Pharmacokinetics and efficacy of chlorpheniramine in children. Journal of Allergy and Clinical Immunology, 69, 376-381.
13. Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T., Falade, C. O., Gbotosho, G. O. & Salako, L. A. (1997). Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 63-67.
14. Wetsteyn, J. C. F. M. & De Geus, A. (1985). Chloroquine-resistant falciparum malaria imported into the Netherlands. Bulletin of the World Health Organization, 63, 101-108.
15. Wiselogie, F. W. (editor) (1946). A Survey of Antimaiarial Drugs, 1941-1945 Inc. Ann Arbor, Michigan, USA: J. W. Edwards, Publishers.
16. WHO (1973). Chemotherapy of Malaria and Resistance to Antimalarials. Geneva: World Health Organization, Technical Report Series, no. 529.
17. WHO (1984). Advances in Malaria Chemotherapy. Geneva: World Health Organization, Technical Report Series, no. 711.
18. WHO (1994). Antimaiarial drug policies: drug requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. Geneva: World Health Organization, mimeographed document WHO/MAL/94.1070.